These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8717066)

  • 1. Distribution and anti-inflammatory effect of mesalazine on carrageenan-induced colitis in the rabbit.
    Kitano A; Matsumoto T; Oshitani N; Nakagawa M; Yasuda K; Watanabe Y; Tomobuchi M; Obayashi M; Tabata A; Fukushima R; Okabe H; Nakamura S; Obata A; Okawa K; Kobayashi K
    Clin Exp Pharmacol Physiol; 1996 Apr; 23(4):305-9. PubMed ID: 8717066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of mesalazine microgranules on experimental colitis].
    Nakamaru K; Sugai T; Hongyo T; Sato M; Taniguchi S; Tanaka Y; Kawase S
    Nihon Yakurigaku Zasshi; 1994 Oct; 104(4):303-11. PubMed ID: 7959421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of mesalazine protects against mucosal injury and permeation in dextran sulfate sodium-induced colitis in rats.
    Hayashi Y; Aoyagi K; Morita I; Yamamoto C; Sakisaka S
    Scand J Gastroenterol; 2009; 44(11):1323-31. PubMed ID: 19891583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease.
    Clemett D; Markham A
    Drugs; 2000 Apr; 59(4):929-56. PubMed ID: 10804042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of slow release mesalazine.
    De Vos M
    Clin Pharmacokinet; 2000 Aug; 39(2):85-97. PubMed ID: 10976656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic uptake of 5-aminosalicylic acid from olsalazine and eudragit L coated mesalazine in patients with ulcerative colitis in remission.
    Ewe K; Becker K; Ueberschaer B
    Z Gastroenterol; 1996 Apr; 34(4):225-9. PubMed ID: 8686349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine.
    Naganuma M; Iwao Y; Ogata H; Inoue N; Funakoshi S; Yamamoto S; Nakamura Y; Ishii H; Hibi T
    Inflamm Bowel Dis; 2001 Aug; 7(3):221-5. PubMed ID: 11515848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mesalazine on the formation of lipoxygenase and cyclooxygenase products.
    Lauritsen K; Laursen LS; Kjeldsen J; Bukhave K; Hansen TK; Rask-Madsen J
    Adv Exp Med Biol; 1995; 371B():1301-6. PubMed ID: 7502805
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of 5-aminosalicylate and para-aminosalicylate on the synthesis of prostaglandin E2 and leukotriene B4 in isolated colonic mucosal cells.
    Schmidt C; Fels T; Baumeister B; Vetter H
    Curr Med Res Opin; 1996; 13(7):417-25. PubMed ID: 8862941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in chronic inflammatory bowel disease.
    Brogden RN; Sorkin EM
    Drugs; 1989 Oct; 38(4):500-23. PubMed ID: 2684592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery and fate of oral mesalamine microgranules within the human small intestine.
    Layer PH; Goebell H; Keller J; Dignass A; Klotz U
    Gastroenterology; 1995 May; 108(5):1427-33. PubMed ID: 7729635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of mesalazine, an agent for the treatment of idiopathic inflammatory bowel disease, on reactive oxygen metabolites and LTB4 formation].
    Nakamaru K; Sugai T; Kinoshita N; Sato M; Taniguchi S; Kawase S
    Nihon Yakurigaku Zasshi; 1994 Dec; 104(6):447-57. PubMed ID: 7851818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment.
    Frieri G; Pimpo MT; Palumbo GC; Onori L; Viscido A; Latella G; Galletti B; Pantaleoni GC; Caprilli R
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1413-7. PubMed ID: 10571596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prophylactic effect of 5-aminosalicylic acid and salazosulphapyridine on degraded-carrageenan-induced colitis in guinea pigs.
    Jensen BH; Andersen JO; Poulsen SS; Skov Olsen P; Nørby Rasmussen S; Hansen SH; Hvidberg EF
    Scand J Gastroenterol; 1984 May; 19(3):299-303. PubMed ID: 6146186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-glutamine enemas attenuate mucosal injury in experimental colitis.
    Kaya E; Gür ES; Ozgüç H; Bayer A; Tokyay R
    Dis Colon Rectum; 1999 Sep; 42(9):1209-15. PubMed ID: 10496564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral mesalazine for the treatment of Crohn's disease: clinical efficacy with respect to pharmacokinetic properties.
    Tromm A; Griga T; May B
    Hepatogastroenterology; 1999; 46(30):3124-35. PubMed ID: 10626173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of mesalazine, metronidazole and gentamicin on bacterial translocation in experimental colitis.
    Yigitler C; Gulec B; Aydogan H; Ozcan A; Kilinc M; Yigit T; Kozak O; Pekcan M
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1179-86. PubMed ID: 15377297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of thromboxane synthase inhibition on in vivo release of inflammatory mediators in chronic ulcerative colitis.
    Casellas F; Papo M; Guarner F; Antolín M; Segura RM; Armengol JR; Malagelada JR
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):221-6. PubMed ID: 7743303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effects of 5-aminosalicylic acid conjugates with chenodeoxycholic acid and ursodeoxycholic acid on carrageenan-induced colitis in guinea-pigs.
    Goto M; Okamoto Y; Yamamoto M; Aki H
    J Pharm Pharmacol; 2001 Dec; 53(12):1711-20. PubMed ID: 11804402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug insight: aminosalicylates for the treatment of IBD.
    Nielsen OH; Munck LK
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.